NCT00032994

Brief Summary

The purpose of this study is to assess Motivational Interviewing (MI) to improve treatment engagement and outcome in subjects seeking treatment for substance abuse.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
422

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Apr 2001

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2001

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

April 5, 2002

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 8, 2002

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2002

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2002

Completed
Last Updated

January 12, 2017

Status Verified

April 1, 2010

Enrollment Period

1.5 years

First QC Date

April 5, 2002

Last Update Submit

January 11, 2017

Conditions

Substance-Related Disorders

Keywords

substance use disorders

Outcome Measures

Primary Outcomes (4)

  • Drug use

  • Retention

  • HIV risk behaviors

  • Psychosocial functioning

Interventions

Behavior TherapyBEHAVIORAL

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals will be eligible for the protocol who: a)Are seeking outpatient treatment for any substance use disorder. b)Are 18 years of age or older. c)Are willing to participate in the protocol (e.g., to be randomized to treatment, be contacted for follow-up assessment, to have their sessions audiotaped). d)Are able to understand and provide written informed consent.

You may not qualify if:

  • Individuals will be excluded who: a)Are not sufficiently medically or psychiatrically stable to participate in outpatient treatment. b)Are seeking detoxification only, methadone maintenance, or residential inpatient treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Lower Eastside Service Center (LESC)

New York, New York, 10007, United States

Location

Willamette Family Treatment Services

Eugene, Oregon, 97402, United States

Location

Changepoint - Cedar Hills Blvd

Portland, Oregon, 97292, United States

Location

ADAPT

Roseburg, Oregon, 97470, United States

Location

Chesterfield County CSB- Substance Abuse Services

Chesterfield, Virginia, 23832, United States

Location

Related Links

MeSH Terms

Conditions

Substance-Related Disorders

Interventions

Behavior Therapy

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Kathleen Carroll, Ph.D.

    VA Connecticut Healthcare System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Purpose
TREATMENT
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 5, 2002

First Posted

April 8, 2002

Study Start

April 1, 2001

Primary Completion

October 1, 2002

Study Completion

October 1, 2002

Last Updated

January 12, 2017

Record last verified: 2010-04

Locations

US(5)